|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| CURRENT ASSETS | |||||||||||||||||
| Cash | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable | |||||||||||||||||
| Prepayments and other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| PROPERTY AND EQUIPMENT | |||||||||||||||||
| Property and equipment | |||||||||||||||||
| Accumulated depreciation | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| OTHER ASSETS | |||||||||||||||||
| Deferred expenses | |||||||||||||||||
| Total other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | |||||||||||||||||
| CURRENT LIABILITIES | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Taxes payable | |||||||||||||||||
| Advances from stockholders | |||||||||||||||||
| Member deposits | |||||||||||||||||
| Accured promotion cost | |||||||||||||||||
| Other accrued expenses and current liabilities | |||||||||||||||||
| Note payable - related party | |||||||||||||||||
| Advances from a related party | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Advances from affiliates | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Commitments and Contingencies | |||||||||||||||||
| STOCKHOLDERS' EQUITY (DEFICIT) | |||||||||||||||||
| Preferred stock par value $0.01: 500,000 shares authorized; none issued or outstanding | |||||||||||||||||
| Common stock par value $0.001: 200,000,000 shares authorized; 2,388,215 and 2,100,215 shares issued and outstanding, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Earnings accumulated during the development stage | |||||||||||||||||
| Accumulated other comprehensive income (loss): | |||||||||||||||||
| Foreign currency translation gain (loss) | |||||||||||||||||
| Total stockholders' equity (deficit) | |||||||||||||||||
| Total liabilities and stockholders' equity (deficit) | |||||||||||||||||
Loading...
